Back
Mitek Systems Vs. Lyra Therapeutics Industry Stock Comparison
Buy
52
MITK
Mitek Systems
Last Price:
$9.46
Seasonality Move:
10.53%
Sell
15
LYRA
Lyra Therapeutics
Last Price:
$7.99
Seasonality Move:
-2.43%
Buy
52
Mitek Systems (MITK)
is a Buy
Is Mitek Systems a Buy, Sell or Hold?
-
The current Mitek Systems [MITK] share price is $9.47. The Score for MITK is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
MITK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
15
Lyra Therapeutics (LYRA)
is a Sell
Is Lyra Therapeutics a Buy, Sell or Hold?
-
The current Lyra Therapeutics [LYRA] share price is $7.95. The Score for LYRA is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
LYRA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
MITK Stock Price Chart
What is Mitek Systems's stock price today?
-
The Mitek Systems share price today is $9.47Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MITK is experiencing buying pressure, which is a positive indicator for future bullish movement.
LYRA Stock Price Chart
What is Lyra Therapeutics's stock price today?
-
The Lyra Therapeutics share price today is $7.95Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYRA is experiencing selling pressure, which indicates risk of future bearish movement.
MITK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.76 | Buy |
Relative Strength Index (14 RSI): | 44.28 | Sell |
Chaikin Money Flow: | 155238 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.41 - 10.09) | Sell |
Bollinger Bands (100): | (8.31 - 9.91) | Buy |
LYRA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.63 | Buy |
Relative Strength Index (14 RSI): | 41.08 | Sell |
Chaikin Money Flow: | -13117 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.86 - 10.86) | Sell |
Bollinger Bands (100): | (3.86 - 12.9) | Sell |
MITK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.43 | Buy |
20-day SMA: | 9.75 | Sell |
50-day SMA: | 9.73 | Sell |
200-day SMA: | 9.4 | Buy |
8-day EMA: | 2.1 | Buy |
20-day EMA: | 0.9 | Buy |
50-day EMA: | 0.37 | Buy |
200-day EMA: | 0.09 | Buy |
LYRA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.23 | Sell |
20-day SMA: | 8.68 | Sell |
50-day SMA: | 10.34 | Sell |
200-day SMA: | 9.43 | Sell |
8-day EMA: | 1.77 | Buy |
20-day EMA: | 0.76 | Buy |
50-day EMA: | 0.31 | Buy |
200-day EMA: | 0.08 | Buy |
Mitek Systems Earnings Growth & MITK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.12 per share, an increase this year of $0.07 per share, and an increase next year of $0.14 per share.
Lyra Therapeutics Earnings Growth & LYRA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.
Mitek Systems Technical Analysis
Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lyra Therapeutics Technical Analysis
Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |